IRBM Reports Breakthrough in Zika Virus Drug Discovery

2026-02-10 - 11:38

ROME, Feb. 10, 2026 /PRNewswire/ — IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough with the discovery of a novel and potent allosteric inhibitor targeting the Zika virus (ZIKV) protease (NS2B-NS3). The findings, published in Nature Communications (doi: 10.1038/s41467-026-68943-x), demonstrate the molecule’s efficacy in preclinical models and represent a